Central Drugs Standard Control Organisation News
)
An expert panel of the Central Drugs Standard Control Organisation had recently approved the antiviral Molnupiravir for restricted use in emergency situations, However, ICMR has raised concern over its side effects.
)
An application of the interchangeability study protocol of Covishield and Covaxin was moved by Christian Medical College (CMC) in Vellore.
"The Phase 4 trials for mixing doses of Covaxin and Covishield will soon take place soon on healthy 300 volunteers," the expert panel said.
Loading...
